Improved metabolic control in pediatric patients with type 1 diabetes: A nationwide prospective 12-year time trends analysis

Diabetes Technology and Therapeutics

Volumn 16, Issue 1, 2014, Pages 33-40

  Dovc, Klemen ^a   Telic, Sasa Starc ^a   Lusa, Lara ^b   Bratanic, Nina ^a   Zerjav Tansek, Mojca ^a   Kotnik, Primoz ^a   Stefanija, Magdalena Avbelj ^a   Battelino, Tadej ^a,b   Bratina, Natasa ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; DIABETIC KETOACIDOSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPOGLYCEMIA; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NEWBORN; ONSET AGE; PRIORITY JOURNAL; TREND STUDY;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUALITY OF LIFE; REGISTRIES; SLOVENIA; TIME FACTORS; YOUNG ADULT;

EID: 84891873759     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0182     Document Type: Article

References (29)

1. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. J Pediatr 1994;125:177-188.
2. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ: Assessment of glycemic control and adolescents with diabetes. Pediatr Diabetes 2009;10(Suppl 12):71-81.
3. American Diabetes Association: Standards of medical care in diabetes - 2013. Diabetes Care 2013;36(Suppl 1):S11-S66.
4. Eeg-Olofsson K, Cederholm J, Nilsson PM, Gudbjornsdó ttir S, Eliasson B; Steering Committee of the Swedish National Diabetes Register: Glycemic and risk factor control in type 1 diabetes: Results from 13,612 patients in a national diabetes register. Diabetes Care 2007;30:496-502. (Pubitemid 46354324)
5. Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamborlane W, Battelino T; Consensus Forum Participants: Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes 2012;13:215-228.
6. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F; European Society for Paediatric Endocrinology; the Lawson Wilkins Pediatric Endocrine Society; International Society for Pediatric and Adolescent Diabetes; American Diabetes Association; European Association for the Study of Diabetes: Use of insulin pump therapy in the pediatric age-group: Consensus statement from European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by American Diabetes Association and the European Association for the Study of diabetes. Diabetes Care 2007;30:1653-1662. (Pubitemid 46871195)
7. Pańkowska E, B1azik M, Dziechciarz P, Szypowska A, Szajewska H: Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: A systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009;10:52-58.
8. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010;(1):CD005103.
9. Pickup JC, Sutton AJ: Severe hypoglycaemia and glycaemic control in Type 1 diabetes: Meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-774.
10. Renard E: Insulin pump use in Europe. Diabetes Technol Ther 2010;12(Suppl 1):S-29-S-32.
11. Nimri R, Weintrob N, Benzaquen H, Ofan R, Fayman G, Phillip M: Insulin pump therapy in youth with type 1 diabetes: A retrospective paired study. Pediatrics 2006;117: 2126-2131. (Pubitemid 46071258)
12. Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J, Schober E, Kaprio E, Saukkonen T, Nicolino M, Tubiana-Rufi N, Klinkert C, Haberland H, Vazeou A, Madacsy L, Zangen D, Cherubini V, Rabbone I, Toni S, de Beaufort C, Bakker-van Waarde W, van den Berg N, Volkov I, Barrio R, Hanas R, Zumsteg U, Kuhlmann B, Aebi C, Schumacher U, Gschwend S, Hindmarsh P, Torres M, Shehadeh N, Phillip M; PedPump Study Group: Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: Experience of the PedPump Study in 17 countries. Diabetologia 2008;51:1594-1601.
13. de Beaufort CE, Swift PG, Skinner CT, Aanstoot HJ, Aman J, Cameron F, Martul P, Chiarelli F, Daneman D, Danne T, Dorchy H, Hoey H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njølstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M; Hvidoere Study Group on Childhood Diabetes 2005: Continuing stability of center differences in pediatric diabetes care: Do advances in diabetes treatment improve outcome The Hvidøre Study Group on Childhood Diabetes. Diabetes Care 2007;30:2245-2250. (Pubitemid 47359026)
14. Rosenbauer J, Dost A, Karges B, Hungele A, Stahl A, Ba chle C, Gerstl EM, Kastendieck C, Hofer SE, Holl RW; DPV Initiative and the German BMBF Competence Network Diabetes Mellitus: Improved metabolic control in children and adolescents with type 1 diabetes: A trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 2012;35:80-86.
15. Radosevic B, Bukara-Radujkovic G, Miljkovic V, Pejicic S, Bratina N, Battelino T: The incidence of type 1 diabetes in Republic of Srpska (Bosnia and Herzegovina) and Slovenia in the period 1998-2010. Pediatr Diabetes 2012;14: 273-279.
16. Patterson CC, Dahlquist GG, Gyu ru s E, Green A, Soltész G; EURODIAB Study Group: Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet 2009;373:2027-2033.
17. Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2009; 10(Suppl 12):134-145.
18. Harrell FE Jr, Lee KL, Pollock BG: Regression models in clinical studies: Determining relationships between predictors and response. J Natl Cancer Inst 1988;80:1199-1202.
19. R Development Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. 2009. www.R-project.org (accessed May 27, 2013).
20. Cinek O, Sumńk Z, de Beaufort C, Rurik I, Vazeou A, Madácsy L, Papo NL, Danne T; SWEET Group: Heterogeneity in the systems of pediatric diabetes care across the European Union. Pediatr Diabetes 2012;13(Suppl 16):5-14.
21. Bratina N, Battelino T: Insulin pumps and continuous glucose monitoring (CGM) in preschool and school-age children: How schools can integrate technology. Pediatr Endocrinol Rev 2010;7(Suppl 3):417-421.
22. Dahlquist GG, Nystrom L, Patterson CC; Swedish Childhood Diabetes Study Group; Diabetes Incidence in Sweden Study Group: Incidence of type 1 diabetes in Sweden among individuals aged 0-34 years, 1983-2007: An analysis of time trends. Diabetes Care 2011;34:1754-1759.
23. Blu her S, Meigen C, Gausche R, Keller E, Pfa ffle R, Sabin M, Werther G, Odeh R, Kiess W: Age-specific stabilization in obesity prevalence in German children: A cross-sectional study from 1999 to 2008. Int J Pediatr Obes 2011;6:199-206.
24. Sulli N, Shashaj B: Long term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: A 4-year follow-up. Diabet Med 2006;23:900-906. (Pubitemid 44141080)
25. Sulmont V, Souchon PF, Gouillard-Darnaud C, Fartura A, Salmon-Musial AS, Lambrecht E, Mauran P, Abely M: Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: Continuous subcutaneous insulin infusion as a first line treatment J Pediatr 2010; 157:103-107.
26. Ronsin O, Jannot-Lamotte MF, Vague P, Lassman-Vague V: Factors related to CSII compliance. Diabetes Metab 2005; 31:90-95. (Pubitemid 40327599)
27. Berghaeuser MA, Kapellen T, Heidtmann B, Haberland H, Klinkert C, Holl RW; German Working Group for Insulin Pump Treatment in Paediatric Patients: Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes 2008;9:590-595.
28. Shalitin S, Lahav-Ritte T, Lebenthal Y, Devries L, Phillip M: Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control Diabetes Technol Ther 2012;14:389-397.
29. Svensson J, Johannesen J, Mortensen HB, Nordly S; Danish Childhood Diabetes Registry: Improved metabolic outcome in a Danish diabetic paediatric population aged 0-18 yr: Results from a nationwide continuous registration. Pediatr Diabetes 2009;10:461-467.